A/Prof Steven David
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
15 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Case Report: Serial stereotactic radiotherapy in lieu of systemic therapy change for oligoprogressive breast cancer: eight courses to 17 metastases.
DOI: 10.3389/fonc.2026.16418762025
Journal article
Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors
DOI: 10.1016/j.breast.2025.1045862024
Journal article
Sustained lymphocyte decreases after treatment for early breast cancer
DOI: 10.1038/s41523-024-00698-42022
Journal article
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
DOI: 10.1016/j.ijrobp.2022.05.0342022
Journal article
Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
DOI: 10.3390/biomedicines100408212022
Conference Proceedings
A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)
DOI: 10.1158/1538-7445.SABCS21-PD10-022021
Journal article
SABR in oligometastatic breast cancer: Current status and future directions
DOI: 10.1016/j.breast.2021.10.009
RECENT SCHOLARLY WORKS
2021
Journal article
Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
DOI: 10.1186/s12885-021-08042-w2021
Journal article
Long-term Survival with 18-Fluorodeoxyglucose Positron Emission Tomography-directed Therapy in Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis
DOI: 10.1016/j.clon.2020.10.0102021
Journal article
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases
DOI: 10.1016/j.ijrobp.2020.10.011